Skip to Content

TEMODAR 180 mg Logo (Temodar Temozolomide 180 mg)

Generic Name: temozolomide

Pill with imprint TEMODAR 180 mg Logo is Orange & White, Capsule-shape and has been identified as Temodar Temozolomide 180 mg. It is supplied by Schering.

Temodar is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temodar Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEMODAR 180 mg Logo

Temodar Temozolomide 180 mg TEMODAR 180 mg Logo
Temodar Temozolomide 180 mg TEMODAR 180 mg Logo
Temodar Temozolomide 180 mg TEMODAR 180 mg Logo
Temodar Temozolomide 180 mg TEMODAR 180 mg Logo

Temodar

Generic Name
temozolomide
Imprint
TEMODAR 180 mg Logo
Strength
Temozolomide 180 mg
Color
Orange & White
Size
20.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Schering
Inactive Ingredients
shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, water, ammonia, potassium hydroxide, ferric oxide red, ferric oxide yellow, titanium dioxide, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00085-1430 Schering-Plough Corporation
54868-5980 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.